Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,055 | 5,122 | 3,281 | 5,028 | 4,746 |
| TOTAL | $4,697 | $5,576 | $3,930 | $5,615 | $5,323 |
| Non-Current Assets | |||||
| PPE Net | 1 | 2 | 3 | 4 | 5 |
| Other Non-Current Assets | 84 | 97 | 109 | 120 | 131 |
| TOTAL | $85 | $99 | $112 | $124 | $136 |
| Total Assets | $4,782 | $5,675 | $4,042 | $5,739 | $5,459 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,317 | 1,297 | 1,361 | 897 | 1,137 |
| Accrued Expenses | 1,388 | 960 | 1,368 | 691 | 531 |
| TOTAL | $2,759 | $2,309 | $2,779 | $1,636 | $1,715 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 30 | 44 | 58 | 71 | 84 |
| TOTAL | $30 | $44 | $58 | $71 | $84 |
| Total Liabilities | $2,789 | $2,353 | $2,837 | $1,707 | $1,799 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,269 | 2,515 | 2,141 | 525 | 525 |
| Retained earnings | -49,037 | -45,678 | -42,786 | -39,740 | -37,793 |
| TOTAL | $1,993 | $3,322 | $1,205 | $4,032 | $3,660 |
| Total Liabilities And Equity | $4,782 | $5,675 | $4,042 | $5,739 | $5,459 |